Dealmakers caution not to expect a quick rebound in US health-care mergers and acquisitions after the second-biggest slump since 2000, Bloomberg reports.
“It’s likely to be a slow start to the year,” said Rick Landgarten, the global head of the health-care and real estate advisory teams at Barclays Plc. Dealmaking prospects will depend at least in part on whether people believe inflation has peaked, which would help calm equity markets and allow debt costs to normalize. Read more.
